British Journal of Cancer - Table of Contents alert Volume 118 Issue 4

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 118, Issue 4 (April 2018) In this issue Editorial Clinical Studies Translational Therapeutics Molecular Diagnostics Cellular & Molecular Biology Epidemiology Also new AOP   Sign up for e-alerts Recommend to your library Web feed Subscribe Editorial Protein kinase D1: gatekeeper of the epithelial phenotype and key regulator of cancer metastasis? Peter Storz British Journal of Cancer 2018 118 :459 - 461; February 20, 2018; 10.1038/bjc.2018.1   Abstract | Full Text Clinical Studies Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer R D Kim, S R Alberts, C Peña, I Genvresse, A Ajavon-Hartmann et al. British Journal of Cancer 2018 118 :462 - 470; January 18, 2018; 10.1038/bjc.2017.428   Abstract | Full Text Postmenopausal breast cancer and oestrogen associations with the IgA-coated and IgA-noncoated faecal microbiota James J Goedert, Xing Hua, Agata Bielecka, Isao Okayasu, Ginger L Milne et al. British Journal of Cancer 2018 118 :471 - 479; January 23, 2018; 10.1038/bjc.2017.435   Abstract | Full Text Immune gene expression and response to chemotherapy in advanced breast cancer Theodoros Foukakis, John Lövrot, Alexios Matikas, Ioannis Zerdes, Julie Lorent et al. British Journal of Cancer 2018 118 :480 - 488; January 25, 2018; 10.1038/bjc.2017.446   Abstract | Full Text Robot-assisted radical prostatectomy vs laparoscopic and open retropubic radical prostatectomy: functional outcomes 18 months after diagnosis from a national cohort study in England Julie Nossiter, Arunan Sujenthiran, Susan C Charman, Paul J Cathcart, Ajay Aggarwal et al. British Journal of Cancer 2018 118 :489 - 494; January 18, 2018; 10.1038/bjc.2017.454   Abstract | Full Text Translational Therapeutics Targeting negative regulation of p53 by MDM2 and WIP1 as a therapeutic strategy in cutaneous melanoma Chiao-En Wu, Arman Esfandiari, Yi-Hsuan Ho, Nan Wang, Ahmed Khairallah Mahdi et al. British Journal of Cancer 2017 118 :495 - 508; December 12, 2017; 10.1038/bjc.2017.433   Abstract | Full Text Interferon-alpha enhances the antitumour activity of EGFR-targeted therapies by upregulating RIG-I in head and neck squamous cell carcinoma Hailong Ma, Shufang Jin, Wenyi Yang, Ge Zhou, Mei Zhao et al. British Journal of Cancer 2018 118 :509 - 521; January 18, 2018; 10.1038/bjc.2017.442   Abstract | Full Text H1/pHGFK1 nanoparticles exert anti-tumoural and radiosensitising effects by inhibition of MET in glioblastoma Wenyan Zhang, Rui Duan, Jian Zhang, William K C Cheung, Xiaoge Gao et al. British Journal of Cancer 2018 118 :522 - 533; January 18, 2018; 10.1038/bjc.2017.461   Abstract | Full Text A novel Epstein–Barr virus-latent membrane protein-1-specific T-cell receptor for TCR gene therapy Hyun-Il Cho, Un-Hee Kim, A-Ri Shin, Ji-Na Won, Hyun-Joo Lee et al. British Journal of Cancer 2018 118 :534 - 545; January 23, 2018; 10.1038/bjc.2017.475   Abstract | Full Text Molecular Diagnostics Cadherin-1 and cadherin-3 cooperation determines the aggressiveness of pancreatic ductal adenocarcinoma Carole Siret, Aurélie Dobric, Anna Martirosyan, Chloé Terciolo, Sébastien Germain et al. British Journal of Cancer 2017 118 :546 - 557; November 21, 2017; 10.1038/bjc.2017.411   Abstract | Full Text LGR5 expression is regulated by EGF in early colorectal adenomas and governs EGFR inhibitor sensitivity R G Morgan, E Mortensson, D N Legge, B Gupta, T J Collard et al. British Journal of Cancer 2017 118 :558 - 565; November 16, 2017; 10.1038/bjc.2017.412   Abstract | Full Text Inflammatory cytokine IL-8/CXCL8 promotes tumour escape from hepatocyte-induced dormancy Ahmad S Khazali, Amanda M Clark & Alan Wells British Journal of Cancer 2017 118 :566 - 576; November 23, 2017; 10.1038/bjc.2017.414   Abstract | Full Text Tumour budding in oral squamous cell carcinoma: a meta-analysis Alhadi Almangush, Matti Pirinen, Ilkka Heikkinen, Antti A Mäkitie, Tuula Salo et al. British Journal of Cancer 2017 118 :577 - 586; November 30, 2017; 10.1038/bjc.2017.425   Abstract | Full Text Cellular & Molecular Biology Protein kinase D1 regulates subcellular localisation and metastatic function of metastasis-associated protein 1 Aditya Ganju, Subhash C Chauhan, Bilal Bin Hafeez, Kyle Doxtater, Manish K Tripathi et al. British Journal of Cancer 2018 118 :587 - 599; February 20, 2018; 10.1038/bjc.2017.431   Abstract | Full Text Epidemiology Domestic light at night and breast cancer risk: a prospective analysis of 105?000 UK women in the Generations Study Louise E Johns, Michael E Jones, Minouk J Schoemaker, Emily McFadden, Alan Ashworth et al. British Journal of Cancer 2018 118 :600 - 606; January 23, 2018; 10.1038/bjc.2017.359   Abstract | Full Text Anthropometric measurements and survival after a prostate cancer diagnosis   British Journal of Cancer 2017 118 :607 - 610; December 12, 2017; 10.1038/bjc.2017.440   Abstract | Full Text Aspirin use and ovarian cancer mortality in a Danish nationwide cohort study Freija Verdoodt, Susanne K Kjaer, Christian Dehlendorff & Søren Friis British Journal of Cancer 2018 118 :611 - 615; January 09, 2018; 10.1038/bjc.2017.449   Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.